Explore Annogen’s News
Annogen incorporated to commercialize SuRE technology for Functional Genome Annotation.
Amsterdam, December 2019 Annogen BV is an Amsterdam based biotech company focussed on functional genome annotation using its proprietary SuRE technology. Its sister company Gen-X BV has just signed an exclusive deal for use of SuRE for gene therapy with uniQure and...